Exelixis Correlations

EXEL Stock

USD 25.15 0.42 1.64%

The current 90-days correlation between Exelixis and CytomX Therapeutics is -0.04 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelixis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelixis moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Exelixis Correlation With Market

Average diversification

The correlation between Exelixis and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

Moving together with Exelixis Stock

0.74	A	Agilent Technologies Fiscal Year End 18th of November 2024	Pair Corr
0.83	AZN	AstraZeneca PLC ADR	Pair Corr
0.74	BIO	Bio Rad Laboratories	Pair Corr
0.84	BMY	Bristol Myers Squibb	Pair Corr
0.82	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.81	SNY	Sanofi ADR	Pair Corr
0.74	TMO	Thermo Fisher Scientific	Pair Corr
0.86	WAT	Waters	Pair Corr
0.73	GILD	Gilead Sciences	Pair Corr

Moving against Exelixis Stock

0.93	ELEV	Elevation Oncology	Pair Corr
0.83	FBRX	Forte Biosciences	Pair Corr
0.82	ESPR	Esperion Therapeutics	Pair Corr
0.77	ME	23Andme Holding	Pair Corr
0.74	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.73	FENC	Fennec Pharmaceuticals	Pair Corr
0.58	DYAI	Dyadic International	Pair Corr
0.55	ERNA	Eterna Therapeutics	Pair Corr
0.48	XFOR	X4 Pharmaceuticals	Pair Corr
0.47	FLGC	Flora Growth Corp	Pair Corr
0.47	KZR	Kezar Life Sciences	Pair Corr
0.43	ENVB	Enveric Biosciences	Pair Corr
0.88	PTN	Palatin Technologies Fiscal Year End 26th of September 2024	Pair Corr
0.88	GNPX	Genprex	Pair Corr
0.88	LPCN	Lipocine	Pair Corr
0.85	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.83	HEPA	Hepion Pharmaceuticals	Pair Corr
0.79	ZVSA	ZyVersa Therapeutics	Pair Corr
0.74	KPRX	Kiora Pharmaceuticals	Pair Corr
0.69	GLSI	Greenwich Lifesciences	Pair Corr
0.67	GENE	Genetic Technologies	Pair Corr
0.49	INBX	Inhibrx Symbol Change	Pair Corr
0.48	LRMR	Larimar Therapeutics	Pair Corr
0.35	LIPO	Lipella Pharmaceuticals	Pair Corr

Related Correlations Analysis

	CTMX	TIL	SPRO	ASMB	ACHL	NXTC	SNTI	SABS	QNRX	BOLT
CTMX		-0.11	0.7	0.09	0.79	-0.28	0.24	0.42	0.54	0.73	CTMX
TIL	-0.11		0.35	0.52	-0.47	0.18	-0.09	0.0	0.33	-0.47	TIL
SPRO	0.7	0.35		0.4	0.5	0.06	0.29	0.5	0.59	0.48	SPRO
ASMB	0.09	0.52	0.4		-0.03	-0.11	0.1	0.28	0.59	-0.19	ASMB
ACHL	0.79	-0.47	0.5	-0.03		-0.19	0.25	0.49	0.37	0.91	ACHL
NXTC	-0.28	0.18	0.06	-0.11	-0.19		-0.13	-0.08	-0.42	0.0	NXTC
SNTI	0.24	-0.09	0.29	0.1	0.25	-0.13		0.48	0.39	0.18	SNTI
SABS	0.42	0.0	0.5	0.28	0.49	-0.08	0.48		0.59	0.47	SABS
QNRX	0.54	0.33	0.59	0.59	0.37	-0.42	0.39	0.59		0.17	QNRX
BOLT	0.73	-0.47	0.48	-0.19	0.91	0.0	0.18	0.47	0.17		BOLT
	CTMX	TIL	SPRO	ASMB	ACHL	NXTC	SNTI	SABS	QNRX	BOLT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BOLT	+ 0.91	ACHL
ACHL	+ 0.79	CTMX
BOLT	+ 0.73	CTMX
SPRO	+ 0.7	CTMX
QNRX	+ 0.59	SPRO
QNRX	+ 0.59	ASMB

High negative correlations

BOLT	- 0.47	TIL
ACHL	- 0.47	TIL
QNRX	- 0.42	NXTC
NXTC	- 0.28	CTMX
NXTC	- 0.19	ACHL
BOLT	- 0.19	ASMB

Risk-Adjusted Indicators

There is a big difference between Exelixis Stock performing well and Exelixis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Exelixis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CTMX	2.87	(0.56)	0.00	(0.20)	0.00	0.00	6.87	(6.30)	17.21
TIL	3.23	0.47	0.17	0.38	2.47	(4.32)	8.40	(4.39)	38.91
SPRO	2.16	(0.13)	0.00	(0.12)	0.00	0.00	4.72	(4.20)	12.84
ASMB	2.82	0.15	0.05	0.15	3.71	(2.83)	6.51	(6.65)	20.11
ACHL	1.74	(0.36)	0.00	(0.44)	0.00	0.00	3.75	(3.61)	10.00
NXTC	3.21	0.10	0.02	0.14	4.10	(3.59)	8.00	(6.37)	23.63
SNTI	6.19	0.23	0.05	0.14	5.94	(8.55)	11.90	(10.21)	68.12
SABS	4.06	0.20	0.03	0.29	5.24	(5.04)	11.50	(8.75)	33.54
QNRX	3.17	0.18	0.03	0.69	3.35	(4.76)	7.14	(7.14)	24.20
BOLT	1.16	(0.27)	0.00	(0.39)	0.00	0.00	2.74	(2.70)	6.93

Exelixis Corporate Management

Amy MD	Product VP	Profile
Laura Dillard	Executive Resources	Profile
Gregg Bernier	VP Marketing	Profile
William MD	Senior Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC